EXACT Sciences Corporation (EXAS)
EXACT Sciences Corporation Gross Profit Margin
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
EXAS Gross Profit Margin Range, Past 5 Years
| Minimum | 59.29% | Sep 2007 |
| Maximum | 99.91% | Jun 2007 |
| Average | 96.53% |
About Gross Profit Margin
Gross profit margin is the difference between sales and the cost of goods sold divided by revenue. It expresses the relationship between gross profit (sales - cost of goods sold) and sales revenue. More specifically, gross profit margin represents the percentage of each dollar of a company's revenue that is available to cover fixed costs after paying for the goods or services that were sold.
If a company produces widgets and earns $32 million in sales but pays $24 million for the items sold, then the company's gross profit margin would be ($32m - $24m)/$32m = %25.
Learn More
You may also be interested in these EXAS related companies
EXAS News
$EXAS http://stks.co/3jdc here is why I'm Loooong $EXAS. confident except for 'net profit margin'. Got any help for me there?
about 20 days ago by devlopr
about 20 days ago by devlopr
Listen to $EXAS Q1 2012 earnings call - live at 10:00 AM, ondemand after - http://stks.co/3bIX
about 28 days ago by earningscast
about 28 days ago by earningscast
Exact Sciences Corp (EXAS) Posts Wider than Expected Q1 Loss of 19c/Share
May 01, 7:37AM Street Insider
May 01, 7:37AM Street Insider
$EXAS filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3aWz
about 29 days ago by MarketBrief
about 29 days ago by MarketBrief
$EXAS forms bullish "Flag" chart pattern. http://stks.co/3JPa
about 47 days ago by RecogniaEvents
about 47 days ago by RecogniaEvents
NEW POST: "The Year the Market Overdosed on Biotechs" http://stks.co/37CC $AMLN $BMY $EXAS $IBB
about 62 days ago by chessNwine
about 62 days ago by chessNwine
Exact Sciences Corporation [EXAS] CEO to Ring The NASDAQ Stock Market Opening Bell
Mar 19, 11:04AM GlobeNewswire
Mar 19, 11:04AM GlobeNewswire
Exact Sciences’ Executives, Colon Cancer Challenge Leaders to Ring Nasdaq Opening Bell
Mar 19, 9:45AM Business Wire
Mar 19, 9:45AM Business Wire
Jefferies Boosts Price Target On Exact Sciences (EXAS) Following Q4, FDA Trial on Track
Feb 24, 12:13PM Street Insider
Feb 24, 12:13PM Street Insider
Auriga Reiterates a 'Buy' on Exact Sciences (EXAS); Raising PT After Q4 Review; Timelines on Track
Feb 24, 12:06PM Street Insider
Feb 24, 12:06PM Street Insider
Exact Sciences Corp (EXAS) Posts Q4 Loss of 18c/Share, Wider than Expected
Feb 23, 7:49AM Street Insider
Feb 23, 7:49AM Street Insider
Exact Sciences Reports Fourth-Quarter, Full-Year 2011 Financial Results
Feb 23, 7:30AM Business Wire
Feb 23, 7:30AM Business Wire
Exact Sciences Announces Appointment of Stoltenberg as Chief Commercial Officer
Feb 20, 4:25PM Business Wire
Feb 20, 4:25PM Business Wire
Exact Sciences (EXAS) Appoints Maneesh K. Arora as Chief Operating Officer
Feb 16, 4:48PM Street Insider
Feb 16, 4:48PM Street Insider
Exact Sciences to Host Fourth-Quarter and Full-Year 2011 Results Webcast and Call
Feb 16, 8:00AM Business Wire
Feb 16, 8:00AM Business Wire
Time for Exact Sciences Presentation at UBS Healthcare Services Conference Revised
Feb 06, 11:45AM Business Wire
Feb 06, 11:45AM Business Wire
Canaccord Genuity Initiates Coverage on Exact Sciences (NASDAQ:EXAS) - Video Summary Posted on www.InvestmentPitch.com
Jan 09, 6:23PM Thomson Reuters ONE
Jan 09, 6:23PM Thomson Reuters ONE
Canaccord Genuity Starts Exact Sciences (EXAS) at Buy; The Earlier The Better
Jan 06, 8:52AM Street Insider
Jan 06, 8:52AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| EXAS | 10.31 | +0.07 | +0.68% | 583.88M |
| EXAR | 8.00 | +0.09 | +1.14% | 355.16M |
| EXAM | 10.94 | +0.07 | +0.64% | 370.67M |
| EWZ | 53.27 | +1.13 | +2.17% | |
| EWX | 40.69 | +1.08 | +2.73% | |
| EWV | 39.25 | +0.47 | +1.21% | |
| EWU | 15.94 | +0.15 | +0.95% | |
| EWQ | 19.04 | +0.31 | +1.66% | |
| EWP | 22.14 | -0.75 | -3.28% | |
| EWO | 14.14 | +0.05 | +0.35% |